Literature DB >> 12087528

Juvenile human T lymphotropic virus type 1-associated myelopathy.

Alexandra P Q C Araújo1, Lucia M C Fontenelle, Paula A B Pádua, Heber S Maia Filho, Abelardo de Q C Araújo.   

Abstract

We report the cases of 5 adolescents with human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis, acquired in all but 1 case from the mother. The first symptom in all patients was difficulty in running, which was present for many years before the final diagnosis was made. Follow-up showed an indolent progression, regardless of treatment strategy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12087528     DOI: 10.1086/341251

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Noninvasive Detection of Antibodies to Human T-Cell Lymphotropic Virus Types 1 and 2 by Use of Oral Fluid.

Authors:  Timothy Woo; Carolina Rosadas; Samreen Ijaz; Steve Dicks; Jennifer H C Tosswill; Richard S Tedder; Graham P Taylor
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

2.  Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian children.

Authors:  Emily A Kendall; Elsa González; Iván Espinoza; Martín Tipismana; Kristien Verdonck; Daniel Clark; Sten H Vermund; Eduardo Gotuzzo
Journal:  J Pediatr       Date:  2009-07-22       Impact factor: 4.406

Review 3.  HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status.

Authors:  Elisabetta Pilotti; Maria V Bianchi; Andrea De Maria; Federica Bozzano; Maria G Romanelli; Umberto Bertazzoni; Claudio Casoli
Journal:  Front Microbiol       Date:  2013-12-23       Impact factor: 5.640

Review 4.  Family Aggregation of Human T-Lymphotropic Virus 1-Associated Diseases: A Systematic Review.

Authors:  Carolina Alvarez; Eduardo Gotuzzo; Anne-Mieke Vandamme; Kristien Verdonck
Journal:  Front Microbiol       Date:  2016-10-28       Impact factor: 5.640

5.  Human T-lymphotropic virus 1 neurologic disease.

Authors:  Abelardo Araújo; Marco Antonio Lima; Marcus Tulius T Silva
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.972

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.